Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms using insulin glargine.
Gomis, Ramon; Storms, Fred; Conget, Ignacio; Sinnassamy, Patrick; Davies, Melanie.
Diabetes Res Clin Pract
; 77(1): 84-91, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17097185
Insulin detemir versus insulin glargine for type 2 diabetes mellitus.
Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes.
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Different intensities of glycaemic control for pregnant women with pre-existing diabetes.
Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes.
Alta incidencia de diabetes tipo 1 en población magrebí de Osona y Baix Camp
A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1.
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
The use of insulin analogues in pregnancy.
Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in Type 1 diabetes mellitus: a systematic review.